WALLIX GROUP (ALLIX.PA) Fundamental Analysis & Valuation

EPA:ALLIX • FR0010131409

Current stock price

21.55 EUR
-1.1 (-4.86%)
Last:

This ALLIX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALLIX.PA Profitability Analysis

1.1 Basic Checks

  • ALLIX had negative earnings in the past year.
  • In the past year ALLIX had a positive cash flow from operations.
  • In the past 5 years ALLIX always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: ALLIX reported negative operating cash flow in multiple years.
ALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

  • The Return On Assets of ALLIX (-1.36%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -8.16%, ALLIX is doing worse than 61.82% of the companies in the same industry.
Industry RankSector Rank
ROA -1.36%
ROE -8.16%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALLIX.PA Yearly ROA, ROE, ROICALLIX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40 -50

1.3 Margins

  • ALLIX's Gross Margin of 104.72% is amongst the best of the industry. ALLIX outperforms 99.09% of its industry peers.
  • ALLIX's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALLIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 104.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.5%
GM growth 5Y-3.41%
ALLIX.PA Yearly Profit, Operating, Gross MarginsALLIX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 100

1

2. ALLIX.PA Health Analysis

2.1 Basic Checks

  • ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALLIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALLIX.PA Yearly Shares OutstandingALLIX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALLIX.PA Yearly Total Debt VS Total AssetsALLIX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of 1.13, we must say that ALLIX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.13, ALLIX is doing worse than 66.36% of the companies in the same industry.
  • The Debt to FCF ratio of ALLIX is 7.88, which is on the high side as it means it would take ALLIX, 7.88 years of fcf income to pay off all of its debts.
  • ALLIX has a Debt to FCF ratio of 7.88. This is comparable to the rest of the industry: ALLIX outperforms 44.55% of its industry peers.
  • ALLIX has a Debt/Equity ratio of 0.76. This is a neutral value indicating ALLIX is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ALLIX (0.76) is worse than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 7.88
Altman-Z 1.13
ROIC/WACCN/A
WACC8.29%
ALLIX.PA Yearly LT Debt VS Equity VS FCFALLIX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 0.89 indicates that ALLIX may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.89, ALLIX is doing worse than 79.09% of the companies in the same industry.
  • A Quick Ratio of 0.89 indicates that ALLIX may have some problems paying its short term obligations.
  • ALLIX's Quick ratio of 0.89 is on the low side compared to the rest of the industry. ALLIX is outperformed by 78.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.89
ALLIX.PA Yearly Current Assets VS Current LiabilitesALLIX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

6

3. ALLIX.PA Growth Analysis

3.1 Past

  • ALLIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.45%, which is quite impressive.
  • The Revenue has grown by 19.15% in the past year. This is quite good.
  • The Revenue has been growing by 15.14% on average over the past years. This is quite good.
EPS 1Y (TTM)80.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.01%
Revenue 1Y (TTM)19.15%
Revenue growth 3Y17.28%
Revenue growth 5Y15.14%
Sales Q2Q%19.37%

3.2 Future

  • ALLIX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 836.75% yearly.
  • Based on estimates for the next years, ALLIX will show a very strong growth in Revenue. The Revenue will grow by 21.27% on average per year.
EPS Next Y3950%
EPS Next 2Y836.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.32%
Revenue Next 2Y21.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALLIX.PA Yearly Revenue VS EstimatesALLIX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALLIX.PA Yearly EPS VS EstimatesALLIX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

3

4. ALLIX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALLIX. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 25.83, ALLIX can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ALLIX.
  • The average S&P500 Price/Forward Earnings ratio is at 23.10. ALLIX is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 25.83
ALLIX.PA Price Earnings VS Forward Price EarningsALLIX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

  • ALLIX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • ALLIX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 139.53
EV/EBITDA 26.53
ALLIX.PA Per share dataALLIX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALLIX's earnings are expected to grow with 836.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y836.75%
EPS Next 3YN/A

0

5. ALLIX.PA Dividend Analysis

5.1 Amount

  • ALLIX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALLIX.PA Fundamentals: All Metrics, Ratios and Statistics

WALLIX GROUP

EPA:ALLIX (4/7/2026, 7:00:00 PM)

21.55

-1.1 (-4.86%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-19
Earnings (Next)07-15
Inst Owners13.23%
Inst Owner ChangeN/A
Ins Owners19.72%
Ins Owner ChangeN/A
Market Cap145.25M
Revenue(TTM)40.62M
Net Income(TTM)-875.00K
Analysts84
Price Target32.64 (51.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.48%
PT rev (3m)4.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.98%
Revenue NY rev (3m)-1.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.83
P/S 3.58
P/FCF 139.53
P/OCF 19.2
P/B 13.54
P/tB N/A
EV/EBITDA 26.53
EPS(TTM)-0.13
EYN/A
EPS(NY)0.83
Fwd EY3.87%
FCF(TTM)0.15
FCFY0.72%
OCF(TTM)1.12
OCFY5.21%
SpS6.03
BVpS1.59
TBVpS-1.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.36%
ROE -8.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 104.72%
FCFM 2.56%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.5%
GM growth 5Y-3.41%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 7.88
Debt/EBITDA 1.54
Cap/Depr 106.22%
Cap/Sales 16.06%
Interest Coverage N/A
Cash Conversion 141.94%
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.89
Altman-Z 1.13
F-Score5
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)117.58%
Cap/Depr(5y)139.36%
Cap/Sales(3y)16.86%
Cap/Sales(5y)19.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.01%
EPS Next Y3950%
EPS Next 2Y836.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.15%
Revenue growth 3Y17.28%
Revenue growth 5Y15.14%
Sales Q2Q%19.37%
Revenue Next Year21.32%
Revenue Next 2Y21.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y85.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8250.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y121.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y388%
OCF growth 3YN/A
OCF growth 5YN/A

WALLIX GROUP / ALLIX.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of WALLIX GROUP (ALLIX.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALLIX.PA.


What is the valuation status for ALLIX stock?

ChartMill assigns a valuation rating of 3 / 10 to WALLIX GROUP (ALLIX.PA). This can be considered as Overvalued.


How profitable is WALLIX GROUP (ALLIX.PA) stock?

WALLIX GROUP (ALLIX.PA) has a profitability rating of 2 / 10.


What is the financial health of WALLIX GROUP (ALLIX.PA) stock?

The financial health rating of WALLIX GROUP (ALLIX.PA) is 1 / 10.